A Proprotein Convertase Subtilisin-like/Kexin Type 9 (PCSK9) C-terminal Domain Antibody Antigen-binding Fragment Inhibits PCSK9 Internalization and Restores Low Density Lipoprotein Uptake
Open Access
- 1 April 2010
- journal article
- Published by Elsevier BV
- Vol. 285 (17), 12882-12891
- https://doi.org/10.1074/jbc.m110.113035
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Antibody-mediated disruption of the interaction between PCSK9 and the low-density lipoprotein receptorBiochemical Journal, 2009
- Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variantsNature Genetics, 2009
- Common variants at 30 loci contribute to polygenic dyslipidemiaNature Genetics, 2008
- PCSK9 and LDL cholesterol: unravelling the target to design the bulletTrends in Biochemical Sciences, 2008
- Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptorProceedings of the National Academy of Sciences of the United States of America, 2008
- The Human Combinatorial Antibody Library HuCAL GOLD Combines Diversification of All Six CDRs According to the Natural Immune System with a Novel Display Method for Efficient Selection of High-Affinity AntibodiesJournal of Molecular Biology, 2008
- Molecular basis for LDL receptor recognition by PCSK9Proceedings of the National Academy of Sciences of the United States of America, 2008
- The self-inhibited structure of full-length PCSK9 at 1.9 Å reveals structural homology with resistin within the C-terminal domainProceedings of the National Academy of Sciences of the United States of America, 2007
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003